SPX3,835.96+4.57 0.12%
DIA310.11+0.40 0.13%
IXIC11,337.27+15.03 0.13%

Sanofi says its COVID-19 booster shot has potential against main variants

Sanofi says its COVID-19 booster shot has potential against main variants

reuters.com · 06/13/2022 01:42
Sanofi says its COVID-19 booster shot has potential against main variants

- French drugmaker Sanofi SASY.PA on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus's main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster jab.

"Across both studies, the Sanofi-GSK next-generation vaccine candidate was well-tolerated, with a favourable safety profile," Sanofi said in a statement, adding that it would publish the complete findings of the studies later this year.


(Reporting by Tassilo Hummel; Editing by Tom Hogue)

((tassilo.hummel@thomsonreuters.com ; Twitter handle: @tassilo_hummel;))